Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer-Reference-Cited by-同舟云学术

Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer

Published:2014-02-11 Issue:1 Volume:9 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Bhattasali Onita,Chen Leonard N,Woo Jennifer,Park Jee-Won,Kim Joy S,Moures Rudy,Yung Thomas,Lei Siyuan,Collins Brian T,Kowalczyk Keith,Suy Simeng,Dritschilo Anatoly,Lynch John H,Collins Sean P

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

https://link.springer.com/content/pdf/10.1186/1748-717X-9-52.pdf

Reference32 articles.

1. King CR, Freeman D, Kaplan I, Fuller D, Bolzicco G, Collins S, Meier R, Wang J, Kupelian P, Steinberg M, Katz A: Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials. Radiother Oncol 2013, 109: 217-221. 10.1016/j.radonc.2013.08.030

2. King CR, Collins S, Fuller D, Wang PC, Kupelian P, Steinberg M, Katz A: Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trials. Int J Radiat Oncol Biol Phys 2013, 87: 939-945. 10.1016/j.ijrobp.2013.08.019

3. Xie Y, Djajaputra D, King CR, Hossain S, Ma L, Xing L: Intrafractional motion of the prostate during hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys 2008, 72: 236-246. 10.1016/j.ijrobp.2008.04.051

4. Lei S, Piel N, Oermann EK, Chen V, Ju AW, Dahal KN, Hanscom HN, Kim JS, Yu X, Zhang G, et al.: Six-dimensional correction of intra-fractional prostate motion with CyberKnife stereotactic body radiation therapy. Front Oncol 2011, 1: 48.

5. Katz AJ, Santoro M, Diblasio F, Ashley R: Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years. Radiat Oncol 2013, 8: 118. 10.1186/1748-717X-8-118

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic Magnetic Resonance–Guided Daily Adaptive Radiation Therapy for Localized Prostate Cancer: Acute and Late Patient-Reported Toxicity Outcomes;Advances in Radiation Oncology;2024-09

2. Stereotactic Body Radiation Therapy for the Curative Treatment of Prostate Cancer in Ultralarge (≥100 cc) Glands;Practical Radiation Oncology;2023-11

3. Genitourinary Quality-of-Life Comparison Between Urethral Sparing Prostate Stereotactic Body Radiation Therapy Monotherapy and Virtual High-Dose-Rate Brachytherapy Boost;International Journal of Radiation Oncology*Biology*Physics;2023-08

4. Dosimetric predictors of acute bowel toxicity after Stereotactic Body Radiotherapy (SBRT) in the definitive treatment of localized prostate cancer;Acta Oncologica;2023-02-01

5. Accumulated bladder wall dose is correlated with patient-reported acute urinary toxicity in prostate cancer patients treated with stereotactic, daily adaptive MR-guided radiotherapy;Radiotherapy and Oncology;2022-06